Expiration Date: 10/31/2023
This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.
This educational activity is highly relevant to pharmacists who frequently practice as part of the interprofessional team in treating patients with pain in hospitals, health systems and ambulatory care centers. Not all pharmacists are intimately familiar with the FDA’s Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), which is essential in order to ensure that patients receive and understand the Medication Guides and information regarding the safe use of these products. With enhanced knowledge and strategies for managing patients with pain, pharmacists can support the interprofessional team in addressing opioid addiction and support the safe use of opioids.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Explain the fundamentals of pain management, including definitions, etiology, and mechanisms of pain.
Discuss both pharmacologic (non-opioid and opioid analgesics) and nonpharmacologic therapeutic options for managing pain.
Develop individualized pain management plans for patients that include therapy goals, pharmacologic and non-pharmacologic options, and interprofessional collaboration.
Counsel patients and caregivers on the safe use of opioid therapy, including proper storage and disposal of medications.
Describe an approach for identifying and managing patients with opioid use disorder.
Fundamentals of Pain Management
Suzanne A Nesbit, PharmD, BCPS, FCCP, FASHP
Optimizing Pain Management
Timothy J Atkinson, PharmD, BCPS
Meeting the Challenges of Chronic Pain Management and Opioid Use Disorder
Chris Herndon, PharmD, BCACP, FASHP
Timothy J. Atkinson, PharmD, BCPS, Activity Chair
Clinical Pharmacy Practitioner, Pain Management
VA Tennessee Valley Healthcare System
Timothy J. Atkinson, PharmD, BCPS is a Clinical Pharmacy Specialist in Pain Management at the Veterans Affairs (VA) Tennessee Valley Healthcare System (TVHS) in Murfreesboro, Tennessee, where he specializes in complex and high-risk pain medication management through direct patient care and electronic consult services within the regional referral pain clinic. He also is Director of the ASHP-accredited PGY2 Pain Management and Palliative Care Residency program at TVHS and represents pain management on the national VA Residency Advisory Board.
Chris Herndon, PharmD, BCACP, FASHP
Southern Illinois University Edwardsville
Chris Herndon, PharmD, BCACP, FASHP, FCCP is a Professor at Southern Illinois University Edwardsville (SIUE) School of Pharmacy. Dr. Herndon sees chronic pain and opioid use disorder patients within a family medicine residency clinic. Dr. Herndon’s scholarship interest focuses primarily on pain and palliative care education and he is the Principal Investigator for the National Institutes of Health Center of Excellence in Pain Education at SIUE. Dr. Herndon was president for the Society of Pain and Palliative Care Pharmacists in 2019, recipient of the Distinguished Service Award from the American Pain Society in 2018, and the Illinois Pharmacist’s Association’s “Pharmacist of the Year” in 2016.
Suzanne A. Nesbit, PharmD, BCPS, FCCP, FASHP
Clinical Pharmacy Specialist, Pain Management
The Johns Hopkins Hospital
Suzanne Amato Nesbit, PharmD, BCPS, FCCP, FASHP is a Clinical Specialist in Pain Management and Palliative Care with the Department of Pharmacy and serves as the Residency Director for the PGY2 Pain Management and Palliative Care Pharmacy Residency at The Johns Hopkins Hospital in Baltimore, Maryland. She also currently serves on the ASHP Commission on Credentialing.
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CPE activity.
This activity consists of the following:
- A pre-assessment completed during registration
- A faculty slide presentation with active learning and faculty discussion
- Supplementary materials
- A post-assessment (a score of at least 70% is required)
- An evaluation completed on the ASHP Learning Center.
Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at the ASHP eLearning Portal. Follow the prompts to complete the post-assessment and evaluation, claim credit, and view the statement of credit immediately after completing the activity.
Claim CE Within 60 Days
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned.
Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify that your credit has posted before the ACPE 60-day deadline.
After ACPE's 60 day deadline, ASHP will no longer be able to report credits for this activity.
There is also an option to download an ASHP Statement of Completion for this REMS-compliant activity.
Provided by ASHP
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies (RPC). Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration (FDA).